Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids as antiangiogenic agents.

Alejandro Oliver1, Thomas A Ciulla

  • 1Department of Ophthalmology, Indiana University School of Medicine, 702 Rotary Circle, Indianapolis, IN 46202, USA.

Ophthalmology Clinics of North America
|August 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene therapy and cost-effectiveness analysis: Current issues and future research.

Med (New York, N.Y.)·2026
Same author

A theoretical model for the influence of age, race and ethnicity on retinal mitochondria dysfunction.

Journal of theoretical biology·2026
Same author

Gene-Agnostic Therapeutic Strategies for Inherited Retinal Diseases: Neuroprotection and Immunomodulation.

Genes·2026
Same author

Biological therapies at 25 years: from incremental advances to revolutionary transformations.

Expert opinion on biological therapy·2026
Same author

Assessing the impact of ophthalmology locum clinic rotation in Northeastern Ontario.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2025
Same author

Beyond the injection: delivery systems reshaping retinal disease management.

Expert opinion on pharmacotherapy·2025

Corticosteroids are increasingly used for neovascular eye diseases due to their ability to inhibit blood vessel growth. Research is advancing understanding of their effectiveness, delivery, and safety in treating retinal conditions.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Molecular Biology

Background:

  • Corticosteroids traditionally treat inflammation.
  • Emerging research highlights their anti-angiogenic properties for ocular conditions.
  • Neovascular ocular diseases present significant treatment challenges.

Purpose of the Study:

  • To review recent findings on angiostatic corticosteroids.
  • To explore their effectiveness and mechanisms in neovascular eye diseases.
  • To discuss novel compounds, delivery methods, and therapeutic strategies.

Main Methods:

  • Review of basic and clinical research.
  • Analysis of corticosteroid compounds targeting angiogenesis.
  • Examination of novel drug delivery systems and treatment regimens.

Related Experiment Videos

Main Results:

  • Corticosteroids demonstrate significant potential in treating neovascular ocular diseases.
  • New compounds and delivery methods are enhancing therapeutic efficacy.
  • Understanding of corticosteroid mechanisms of action is improving.

Conclusions:

  • Angiostatic corticosteroids are becoming a key treatment modality for retinal diseases.
  • Ongoing research focuses on optimizing administration and safety profiles.
  • Further advancements are expected in managing angiogenesis-driven ocular pathologies.